Initiated operations in the designated year we functioned, During 2022 under the name m/s ddk healthcare serve as a distinguished establishment that is operating as a bulk distributor of a broad selection of daclatasvir sofosbuvir tablets 400mg, Myhep dvir tablet and, Aprazer 100mg imatikast tablet, And sofosbuvir tablets 60mg 25mg taffic tablets, Among others situated in delhi, India, Our business operates as a single-owner entity firm the provided goods in alignment with the defined sector specifications norms.
Our Story
Company Introduction Watch Video
No introduction video available
Company Overview

Learn about Ddk Healthcare and its focus on Wholesaler.

Company Timeline
2022 Founded

Ddk Healthcare was founded in 2022. The company is based in New Delhi, India. Initiated operations in the designated year we functioned, During 2022 under the name m/s ddk healthcare serve as a distinguished establishment that is operating as a bulk distributor of a broad selection of daclatasvir sofosbuvir tablets 4...

2026 Global Expansion

Ddk Healthcare focuses on Wholesaler.

Overview

Monthly Supply Capacity

-

Annual Turnover

Upto ₹50 Lakh

Main Markets

-

Nearest Export Port

-

Accepted Delivery Terms

-

Key Facts
Team Size
N/A

Skilled professionals across R&D, manufacturing, and support

Annual Turnover
Upto ₹50 Lakh

Consistent growth with strong financial performance

Main Markets
N/A

Worldwide presence with dedicated regional support

Manufacturing Excellence
-
Factory Area
2
Production Lines

State-of-the-art manufacturing facility with automated production lines and strict quality control processes.